Opinion
A Terminal Diagnosis
Many institutional portfolios are built on assumptions that may not survive the decade. Those planning ahead are building immunity.
Many institutional portfolios are built on assumptions that may not survive the decade. Those planning ahead are building immunity.
Shifts coming at the portfolio construction and market levels mean allocators need to stay focused on their goals.
Both approaches have benefits, but the current market volatility has changed how allocators weigh cost and governance differences.
The Intentional Endowments Network reviews what endowments and foundations need to know about artificial intelligence.
While not a driver of growth in exchange-traded funds, institutional investors have found new use cases for the investment vehicles.